Sangamo Therapeutics ran out of cash. Eli Lilly and Astellas want the science it spent decades building.
View post: A battle 3,000 miles away could shape Palantir’s next move The healthcare sector was expected to complete 2024 with remarkable strength and 27% fewer bankruptcy filings than in 2023, based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results